The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
12-Mar-09
$46.9 billion
Target:
Genentech, Inc.
Acquiror:
Roche Holding Ltd.
Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company
15-Dec-19
$45.4 billion
Target:
Nutrition & Biosciences Division of DuPont de Nemours, Inc.
Acquiror:
International Flavors and Fragrances, Inc.
Advising IFF, a global leader in flavors and fragrances, on its merger with DuPont’s Nutrition & Biosciences Division, creating a clear global leader in the specialty ingredients sector
27-Jul-15
$40.5 billion
Target:
Allergan Generics
Acquiror:
Teva Pharmaceutical Industries Ltd.
Advised Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, on the acquisition of Allergan plc’s Generics business
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
30-Mar-07
$24.4 billion
Target:
Alliance Boots plc
Acquiror:
Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina
Advised Alliance Boots plc, the leading international pharmacy-led health and beauty group, on a proposal regarding an offer for the company from a consortium comprising of Kohlberg Kravis Roberts & Co. Ltd. and Stefano Pessina
25-Apr-03
$20.8 billion
Target:
AMR Corporation
Advised AMR, parent of American Airlines, on strategic alternatives and implementation of a historic out-of-court restructuring through which a variety of stakeholder concessions were achieved, averting bankruptcy
15-Dec-06
$19.1 billion
Target:
Gallaher Group plc
Acquiror:
Japan Tobacco Inc.
Advised Gallaher Group plc, the world’s fifth largest tobacco company, on a recommended cash offer from Japan Tobacco Inc
09-Mar-09
$18.6 billion
Target:
Rohm & Haas Company
Acquiror:
The Dow Chemical Company
Advised The Dow Chemical Company during its negotiations pertaining to the Rohm & Haas settlement resolution
14-Apr-08
$17.7 billion+
Target:
Northwest Airlines
Acquiror:
Delta Air Lines
Advised Delta Air Lines in connection with its merger with Northwest Airlines (+Transaction value represents enterprise value of combined entity)
26-Jan-15
$16.0 billion
Target:
MeadWestvaco Corporation
Acquiror:
Rock-Tenn Company
Provided fairness opinion to the Board of Directors of MeadWestvaco on the merger with RockTenn to create a powerful global provider of consumer and corrugated packaging solutions
25-Feb-10
$14.4 billion
Target:
Coca-Cola Enterprises Inc.
Acquiror:
The Coca-Cola Company
Advised the Affiliated Transaction Committee of Coca-Cola Enterprises Inc. on the sale of its North American bottling operations to The Coca-Cola Company and on its concurrent acquisition of The Coca-Cola Company’s bottling operations in the Nordic region
27-Mar-18
$13.0 billion
Target:
Novartis AG’s 36.5% stake in Consumer Health Joint Venture
Acquiror:
GlaxoSmithKline plc
Advised and acted as sponsor to GlaxoSmithKline plc, the UK’s leading pharmaceutical company, on the buyout of Novartis’ 36.5% stake in their Consumer Health Joint Venture
15-Dec-10
$12.9 billion
Target:
Alcon, Inc.
Acquiror:
Novartis AG
Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company
16-Jan-01
$11.5 billion
Target:
Ralston Purina Co.
Acquiror:
Nestlé S.A.
Advised Nestlé on the agreed cash offer for the US pet-food company Ralston Purina
09-Mar-20
$10.6 billion
Target:
Tesco plc’s Thailand and Malaysia businesses
Acquiror:
Charoen Pokphand Group
Advised Tesco plc, a leading UK retailer, on the sale of its Thailand and Malaysia businesses to Charoen Pokphand Group, the Thai conglomerate
17-Jul-00
$10.5 billion
Target:
Diageo plc
Acquiror:
General Mills, Inc.
Advised Diageo on the sale of The Pillsbury Company for $5.1 billion in assumed debt and $5.4 billion in stock to General Mills.
28-Mar-12
$10.4 billion+
Target:
Flow Control Business of Tyco International Ltd.
Acquiror:
Pentair, Inc.
Provided fairness opinion to the Board of Directors of Pentair, Inc. in connection with its all-stock merger with Tyco Flow Control, a division of Tyco International Ltd. (+Transaction value represents enterprise value of combined entity)
19-Apr-01
$10.0 billion
Target:
GKN plc
Acquiror:
Brambles Industries Ltd
(Industrial Services)
Advised Brambles on its merger with the industrial services division of GKN under a dual listed companies structure
06-Mar-14
$10.0 billion
Target:
Safeway Inc.
Acquiror:
Albertsons (majority owned by Cerberus Capital Management)
Advised the Board of Directors of Safeway Inc., a leading food and drug retailer, on its acquisition by Albertsons
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
19-Feb-15
$8.4 billion
Target:
Rexam plc
Acquiror:
Ball Corporation
Advised Ball Corporation, a leading manufacturer of metal packaging products for the global beverage, food, personal care and household products industries as well as a provider of systems and technologies for the aerospace industry, on the acquisition of Rexam plc, a leading beverage can manufacturer
19-Dec-00
$8.2 billion
Target:
Seagram
Acquiror:
Diageo plc and Pernod Ricard
(Spirits Division)
Advised Diageo on its joint agreed bid with Pernod Ricard for Seagram’s spirits business.
11-Oct-22
Pending
$7.9 billion
Target:
Westinghouse Electric Company
Acquiror:
Brookfield Renewable Partners and Cameco
Advising the Independent Committee of Brookfield Renewable Partners, the flagship listed renewable power company of Brookfield Asset Management, in consortium with Cameco and other institutional partners, on the acquisition of Westinghouse Electric Company, one of the world’s largest nuclear services businesses, from Brookfield Business Partners
20-Aug-12
$7.3 billion
Target:
Coventry Health Care Inc.
Acquiror:
Aetna
Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna
19-May-05
$7.2 billion+
Target:
US Airways Group
Acquiror:
America West Holdings
Advised America West Holdings in connection with its merger with US Airways Group. (+Transaction value represents enterprise value of combined entity, including capitalized operating leases of $4.8 billion)